Skip to content

Effects of a Home-based Exercise Program on Functional Capacity and Quality of Life in Heart Failure Patients

Effects of a Home-based Exercise Program on Functional Capacity and Quality of Life in Heart Failure Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03615157
Enrollment
30
Registered
2018-08-03
Start date
2018-01-15
Completion date
2019-02-15
Last updated
2018-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Heart Failure

Keywords

Home-based exercise, Functional capacity, Chronic Heart Failure

Brief summary

Heart failure (HF) is a multisystemic disease leading to exercise intolerance and fatigue. Supervised physical training improves functional capacity, quality of life and reduces hospital admissions in HF patients. In this way, home physical training may be a good alternative to patients who, for any reason, cannot perform supervised training. Objective: To asses the effects of a home-based training program on functional capacity, sedentary lifestyle and quality of life of patients with chronic HF compared to supervised training.

Detailed description

After agreement with the written informed consent, subjects with heart failure (left ventricle ejection fraction bellow or equal 40%) will be included in this study. They will be randomized in two groups: Home-based and Supervised exercise groups. The two groups will be submitted to a twelve-week combined exercise program of aerobic and peripheral muscle training. All volunteers will be assessed at baseline and after twelve weeks of intervention. Peripheric and respiratory muscle strength as well the 6MW analyses were assessed also at 4 and 8 weeks after baseline.

Interventions

Patients will be submitted to a twelve-week combined exercise program of aerobic and peripheral muscle training. They will be randomized in two groups: Home-based and Supervised.

Sponsors

Instituto Dante Pazzanese de Cardiologia
CollaboratorOTHER
InCor Heart Institute
CollaboratorOTHER
Fundação de Amparo à Pesquisa do Estado de São Paulo
CollaboratorOTHER_GOV
University of Sao Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

The participants will be randomized in two groups: Home-based and Supervised exercise groups

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Chronic heart failure (functional class from NYHA II and III), * Left ventricle ejection fraction bellow or equal to 40% * Clinical stability during the last three months * Medical release for physical training after cardiopulmonary test

Exclusion criteria

* Uncontrolled arrhythmia * Pulmonary artery systolic pressure \> 35 mmHg by the echo doppler cardiogram, * Peripheral oxygen saturation \< 92% in resting condition * Respiratory infection in the previous 30 days to the enrollment into the study * Cognitive, neurological or orthopedic limitations

Design outcomes

Primary

MeasureTime frameDescription
Changes in peak oxygen uptake (ml/kg/min)Baseline and after 12 weeks of exercise programsPatients will be submitted to cardiopulmonary treadmill exercise tests at baseline and after 12 weeks.

Secondary

MeasureTime frameDescription
Changes in distance from the six minute walk test (6MW, m)Baseline and after 4, 8 and 12 weeks of exercise programsPatients will be submitted to the 6MW accordingly to the American Thoracic guidelines to assess functional capacity using the six minute walk test
Changes in respiratory muscle strength (cmH2O)Baseline and after 4, 8 and 12 weeks of exercise programsInspiratory and expiratory muscle strength will be assessed using an analogic pressure transducer
Changes in peripheral muscle strength (N) - Quadriceps mmBaseline and after 4, 8 and 12 weeks of exercise programQuadriceps strength will be assessed by MicroFet 2 dynamometer (HogganHealth, USA)
Changes in peripheral muscle strength (kgf) - Hand gripBaseline and after 4, 8 and 12 weeks of exercise programsHand grip strength will be assessed by Jamar dynamometer (Sammons Preston Rolyan, 4, Sammons Court, Bolingbrook, IL, 60440)
Changes in daily physical activity and sedentary lifestyleBaseline and after 12 weeks of exercise programsPatients will use the accelerometer GT3X (Actigraph, Pensacola, FL, USA) on waist during 9 days to asses daily physical activity and sedentary lifestyle
Changes in International Physical Activity Questionnaire (IPAQ)Baseline and after 12 weeks of exercise programsPatients will be classified as sedentary, irregularly active, active or very active according to Matsudo's Classification (2001)
Incidence of cardiac events and arrhythmiaBaseline and after 12 weeks of exercise programsBy a 24-hours holter system for continuous recording of ambulatory electrocardiographic signs
Changes in quality of life using MLHFBaseline and after 12 weeks of exercise programsQuality of life will be assessed by the Minnesota Living with Heart Failure Questionnaire
Changes in brain natriuretic peptide (BNP, pg/mL)Baseline and after 12 weeks of exercise programsA blood sample of 5 ml will be collected in a tube and BNP will be measured
Changes in heart rate variability (HRV)Baseline and after 12 weeks of exercise programsHRV will be analysed from the spectral analysis of R-R intervals obtained from a heart rate monitor (Polar, S810, Kempele, Finland) during the 6MW
Changes in sleep qualityBaseline and after 12 weeks of exercise programsPatients will use the accelerometer GT3X (Actigraph, Pensacola, FL, USA) on wrist for nine days to asses Sleep quality. Furthermore, the Pittsburgh Sleep Quality Index will be used to classify patients as good or poor sleepers.
Changes in daytime sleepinessBaseline and after 12 weeks of exercise programsDaytime sleepiness will be assessed by the Epworth Sleepiness Scale
Changes in quality of life using SF-36Baseline and after 12 weeks of exercise programsQuality of life will be assessed by the Short Form-36 Questionnaire

Countries

Brazil

Contacts

Primary ContactNaomi K Nakagawa, PhD
naomi.kondo@fm.usp.br+551130618529
Backup ContactGeisa N Andrade
geisandrade@usp.br+5511993038655

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026